Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score
MÁ Martínez-García, J De Gracia… - European …, 2014 - Eur Respiratory Soc
Bronchiectasis is a multidimensional disease and, therefore, its severity or prognosis cannot
be adequately quantified by analysing one single variable. The objective of the present …
be adequately quantified by analysing one single variable. The objective of the present …
Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients
PC Goeminne, H Scheers, A Decraene, S Seys… - Respiratory …, 2012 - Springer
Introduction There is a relative lack of information about the death rate and morbidity of non-
cystic fibrosis bronchiectasis and most studies are limited due to referral bias. We wanted to …
cystic fibrosis bronchiectasis and most studies are limited due to referral bias. We wanted to …
Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts
MJ McDonnell, S Aliberti, PC Goeminne, K Dimakou… - Thorax, 2016 - thorax.bmj.com
Introduction Bronchiectasis is a multidimensional disease associated with substantial
morbidity and mortality. Two disease-specific clinical prediction tools have been developed …
morbidity and mortality. Two disease-specific clinical prediction tools have been developed …
The multiple faces of non–cystic fibrosis bronchiectasis. A cluster Analysis approach
MÁ Martínez-García, M Vendrell, R Giron… - Annals of the …, 2016 - atsjournals.org
Rationale: The clinical presentation and prognosis of non–cystic fibrosis bronchiectasis are
both very heterogeneous. Objectives: To identify different clinical phenotypes for non–cystic …
both very heterogeneous. Objectives: To identify different clinical phenotypes for non–cystic …
Etiology of non–cystic fibrosis bronchiectasis in adults and its correlation to disease severity
S Lonni, JD Chalmers, PC Goeminne… - Annals of the …, 2015 - atsjournals.org
Rationale: Testing for underlying etiology is a key part of bronchiectasis management, but it
is unclear whether the same extent of testing is required across the spectrum of disease …
is unclear whether the same extent of testing is required across the spectrum of disease …
Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study
HC Ellis, S Cowman, M Fernandes… - European …, 2016 - Eur Respiratory Soc
The clinical course of bronchiectasis is unpredictable, posing a challenge both in clinical
practice and in research. Two mortality prediction scores, the bronchiectasis severity index …
practice and in research. Two mortality prediction scores, the bronchiectasis severity index …
The bronchiectasis severity index. An international derivation and validation study
JD Chalmers, P Goeminne, S Aliberti… - American journal of …, 2014 - atsjournals.org
Rationale: There are no risk stratification tools for morbidity and mortality in bronchiectasis.
Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for …
Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for …
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study
MJ McDonnell, S Aliberti, PC Goeminne… - The lancet Respiratory …, 2016 - thelancet.com
Background Patients with bronchiectasis often have concurrent comorbidities, but the
nature, prevalence, and impact of these comorbidities on disease severity and outcome are …
nature, prevalence, and impact of these comorbidities on disease severity and outcome are …
The EMBARC European Bronchiectasis Registry: protocol for an international observational study
Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no
approved therapies and few large-scale, representative epidemiological studies. The …
approved therapies and few large-scale, representative epidemiological studies. The …
[HTML][HTML] Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis
Introduction There is limited data on mortality and associated morbidity in non-cystic fibrosis
bronchiectasis (NCFB). Our aim was to analyze the overall mortality for all newly diagnosed …
bronchiectasis (NCFB). Our aim was to analyze the overall mortality for all newly diagnosed …